Dr. Minnie Sarwal is a key opinion leader in clinical and translational research that focuses on native organ diseases and organ transplantation. She was Principal Investigator of the parent R01 grant (R01DK109720) entitled “CD40 Autoantibody and FSGS Recurrence.” Her training and decades-long contribution to clinical and basic science stemmed from her career both at Stanford University, where she was Medical Director of the Pediatric Kidney Transplant Program, and at the University of California San Francisco (UCSF), where she is Co-Director of the Kidney-Pancreas Transplant Program and Director of the Precision Transplant Medicine program.
Minnie is also Co-Director of the T32 training grant in Transplant Surgery. Her research has focused on mechanisms and biomarkers for understanding renal transplant injury, and on improving diagnosis and therapies for renal diseases such as diabetes, IgA, and FSGS, with a primary focus on improving diagnostics for solid organ and bone marrow transplantation. To interrogate biological systems, her lab is using multi-omic assays and bioinformatics. Her lab has published in high impact journals such as the NEJM, PNAS, Nature Medicine, Nature Methods, Journal of Immunology, Journal of Experimental Methods, PLOS Medicine, and Science Translational Medicine.